Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
about
Cytotoxic effect of trans-cinnamaldehyde on human leukemia K562 cells.CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-gamma stimulation.Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitroGrowth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascitesEfficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer.Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitroTandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy.Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells.Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
P2860
Q33557490-43D95A23-462E-438D-B27B-6D5CC6439695Q34117090-6B840176-9CAF-4397-8501-AD01042B075AQ34128227-3AE88EE6-BD17-4D5C-9B4B-DEDFBBD93CC3Q34382415-E1C4172D-BB2F-428F-BED2-7323D3027294Q34450648-9A0195B3-D579-44CB-868C-513BC3311D0CQ34769958-04D7B9BA-D989-466C-9B28-95B11B560A8AQ36422925-EA1B9FD3-E618-4EFA-847E-6413639998D7Q36603716-4535837C-11BF-492B-968E-54FAF57A3587Q37038276-1EA1D8DF-A657-4410-907B-7CE0F2FB377BQ37412513-25434FC5-3828-4082-8B0B-72D050C120E4Q38773798-39F5E88E-5B15-4295-A0BD-BC8E641CEA6CQ38848219-6FF686C1-4C5B-4FD3-9B0F-B2ED4CB0AC08Q38877731-D4B3A035-0055-4999-9256-302C290E0194Q39149552-228F725C-4191-4428-901A-CF39E3AC8536Q39399171-7D205397-7071-4377-A1D2-D4F74981B742Q42174988-C20A5559-D380-4229-8836-718B53DA7F72Q42630930-E3628F2B-1814-4D26-83E9-EF70196EDE87Q48473146-FB0A476D-6347-4759-88CB-8B9A8F665E57Q50483304-73D5615C-9711-478E-9194-2B9AE5A73265Q52882119-AEA41148-E6BA-4831-8DCC-F69D39A8E67B
P2860
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@en
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@nl
type
label
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@en
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@nl
prefLabel
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@en
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@nl
P2093
P356
P1476
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
@en
P2093
Kornacker M
Verneris MR
P2888
P304
P356
10.1007/S002620000111
P577
2000-08-01T00:00:00Z